Del Rey Sinus & Allergy Institute® First in Southern California to Complete Implant With Innovative Sinuva™ Sinus Device
Intersect ENT, Inc. (XENT)
Last intersect ent, inc. earnings: 2/24 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intersectent.com/investor-relations
Company Research
Source: PR Web
MARINA DEL REY, Calif. (PRWEB) April 03, 2018 Farhad Sigari, MD, FACS, founder of Del Rey Sinus & Allergy Institute and a leading ear nose and throat (ENT) doctor, has performed the first implant in Southern California, and one of few in the United States, of the new Sinuva sinus device. Approved by the U.S. Food and Drug Administration in December, 2017, Intersect ENT's Sinuva implant is designed to treat recurring nasal polyps in adults who have had prior ethmoid sinus surgery (ESS). "Nasal polyps are one of the most persistent and troublesome conditions that we see in our practice," said Dr. Sigari, a board-certified otolaryngologist. "Even when we surgically remove nasal polyps and the patient exercises ongoing care using steroid sprays or pills, they can return time and again. We are proud to offer this new, advanced and effective treatment choice for patients who have chronic nasal polyps."Nasal polyps are noncancerous, inflammatory growths along the lining of the nasal passage
Show less
Read more
Impact Snapshot
Event Time:
XENT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XENT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XENT alerts
High impacting Intersect ENT, Inc. news events
Weekly update
A roundup of the hottest topics